{"result": {"id": "chatcmpl-151", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**Aflibercept** is a monotherapy used to treat **choroidal neovascularization (CNV)**. It is an anti-VEGF antibody that blocks the action of vascular endothelial growth factor (VEGF), which plays a role in blood vessel formation.  \n\nAflibercept is a drug used to treat various conditions, including those related to eye diseases. It specifically targets neovascularization and acts as an anti-VEGF antibody, helping to manage retinal fluid buildup.  It's also categorized as a drug used for treatment purposes. In the context of anti-angiogenesis therapy for myopic CNV, **Aflibercept** is an anti-VEGF agent known by its drug name. It is particularly effective in treating inflammatory CNV and other eye conditions, including age-related macular degeneration (AMD).  It's also used in research settings. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743185889, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 176, "prompt_tokens": 328, "total_tokens": 504, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"AFLIBERCEPT\"\nDescription List: [\"**Aflibercept** is a monotherapy used to treat **CNV** (choroidal neovascularization). It is an anti-VEGF antibody, meaning it blocks the action of vascular endothelial growth factor (VEGF), which plays a role in blood vessel formation. \\n\", \"The **Aflibercept** is a drug used to treat various conditions, including those related to eye diseases. It specifically targets neovascularization and acts as an anti-VEGF antibody, helping to manage retinal fluid buildup.  It's also categorized as a drug used for treatment purposes. In the context of anti-angiogenesis therapy for myopic central nervous system (CNV), **Aflibercept** is an anti-VEGF agent known by its drug name. It is particularly effective in treating inflammatory CNV and other eye conditions, including age-related macular degeneration (AMD).  It's also used in research settings. \\n\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_c5b011fef424e5262a1b540620855d7051185f3624cb5b448d350e6cff9ffcc7_v2"}